Cancer Screening (Afternoon) Plan - Heart Protection

US$561
NT$18,000 · you pay the hospital in NT$
Book this checkup

Prefer to book it yourself? Call China Medical University Hsinchu Hospital on (03)5580-558 ext. 1240 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A premium-tier program with Coronary artery calcium score, Bone density (DXA) and Resting ECG and a 53-test panel.

Fasting
6 hours before
English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Coronary artery calcium score

Calcified plaque in heart arteries; refines heart attack risk.

Bone density (DXA)

Osteoporosis and fracture risk.

Resting ECG

Heart rhythm and signs of prior heart damage.

Every test, in English

53 tests listed, 38 of them on our shared test list, so they line up against other hospitals' packages.

Vitals5
Blood Count2
Liver Function5
Kidney & Electrolytes4
Lipids & Cardiometabolic4
Glucose3
Thyroid & Endocrine1
Tumor Markers4
Urine & Stool1
Cardiac1
X-ray2
CT Imaging1
Bone & Body Composition1
Eye3
ENT & Dental1
Show all 53 tests and what each screens for
TestScreens for
Vitals
Blood pressureScreens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysisBody fat, muscle mass and water percentage.
Height, weight and BMIBasic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumferenceCentral obesity, a marker of metabolic risk.
Blood Count
Complete blood countAnemia, infection and blood cell disorders.
Vitamin B12 and folateDeficiencies that cause anemia and nerve problems.
Liver Function
ALT (SGPT)Liver cell damage; the most common liver screening test.
AST (SGOT)Liver cell damage.
Direct bilirubinBile duct obstruction.
Gamma-GTBile duct and alcohol-related liver stress.
Total bilirubinJaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CreatinineKidney function.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Fasting insulinInsulin resistance.
Thyroid & Endocrine
Vitamin D (25-OH)Vitamin D deficiency; bone health.
Tumor Markers
CEAColorectal and other GI cancer marker.
CYFRA 21-1Lung cancer marker.
EBV VCA-IgANasopharyngeal cancer risk (common in Taiwan and southern China).
PSAProstate cancer marker.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Cardiac
Resting ECGHeart rhythm and signs of prior heart damage.
X-ray
Abdominal X-ray (KUB)Kidney stones and bowel abnormalities.
Spine X-rayDegeneration and alignment of the spine.
CT Imaging
Coronary artery calcium scoreCalcified plaque in heart arteries; refines heart attack risk.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Eye
Color visionColor vision deficiency.
Intraocular pressureGlaucoma.
Visual acuityVision sharpness.
ENT & Dental
Hearing testHearing loss.
Vitals
Blood pressure
Screens for hypertension, a major risk factor for heart disease and stroke.
Body composition analysis
Body fat, muscle mass and water percentage.
Height, weight and BMI
Basic body measurements used to assess weight-related health risk.
Basic vital signs (pulse, temperature, respiration)
Basic pulse, temperature and breathing rate measurements taken during a checkup.
Waist circumference
Central obesity, a marker of metabolic risk.
Blood Count
Complete blood count
Anemia, infection and blood cell disorders.
Vitamin B12 and folate
Deficiencies that cause anemia and nerve problems.
Liver Function
ALT (SGPT)
Liver cell damage; the most common liver screening test.
AST (SGOT)
Liver cell damage.
Direct bilirubin
Bile duct obstruction.
Gamma-GT
Bile duct and alcohol-related liver stress.
Total bilirubin
Jaundice, liver and bile problems.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Creatinine
Kidney function.
Estimated GFR
Kidney filtering capacity; stages chronic kidney disease.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Fasting insulin
Insulin resistance.
Thyroid & Endocrine
Vitamin D (25-OH)
Vitamin D deficiency; bone health.
Tumor Markers
CEA
Colorectal and other GI cancer marker.
CYFRA 21-1
Lung cancer marker.
EBV VCA-IgA
Nasopharyngeal cancer risk (common in Taiwan and southern China).
PSA
Prostate cancer marker.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Cardiac
Resting ECG
Heart rhythm and signs of prior heart damage.
X-ray
Abdominal X-ray (KUB)
Kidney stones and bowel abnormalities.
Spine X-ray
Degeneration and alignment of the spine.
CT Imaging
Coronary artery calcium score
Calcified plaque in heart arteries; refines heart attack risk.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Eye
Color vision
Color vision deficiency.
Intraocular pressure
Glaucoma.
Visual acuity
Vision sharpness.
ENT & Dental
Hearing test
Hearing loss.
Also listed: Breast cancer marker, Chest, Fasting insulin, Gastric cancer marker, Kidney cancer marker (Beta-2 microglobulin), MCH (mean corpuscular hemoglobin), MCHC (mean corpuscular hemoglobin concentration), Ovarian cancer marker, PIVKA-II, Pancreatic cancer marker, SCC antigen, Urine color, Urine protein, Urine turbidity, Urobilinogen.

Before you book

Fasting6 hours before
If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
China Medical University Hsinchu Hospital Health Management Center
District hospital
Hsinchu · Zhubei

13 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • For the afternoon cancer-screening checkup program, check-in is from 1:30 PM to 3:00 PM.

    Source ↗ · checked 2026-09-20

  • The center states that items within a health checkup package may not be exchanged or refunded.

    Source ↗ · checked 2026-09-20

  • For the afternoon checkup session, check-in is from 1:00 PM to 3:00 PM.

    Source ↗ · checked 2026-09-20

Before and on the day
  • For the afternoon cancer-screening checkup program, patients must fast from food and water for 6 hours before the exam.

    Source ↗ · checked 2026-09-20

  • The center asks patients to keep to a light diet and avoid all dietary supplements for 3 days before the exam.

    Source ↗ · checked 2026-09-20

  • The center asks patients to fast from all food, drinks, water and gum starting at midnight the night before the exam, an 8-hour fast, and to check in at the time the nurse notifies them.

    Source ↗ · checked 2026-09-20

  • The center asks patients to finish eating by 7 AM on the exam day, then fast from all food, drinks, water and gum for 6 hours, and to check in at the time the nurse notifies them.

    Source ↗ · checked 2026-09-20

  • The center says the latest check-in time it will accept is 3:00 PM; after that it will not help reschedule the appointment.

    Source ↗ · checked 2026-09-20

  • For guests booked for a Pap smear, the center asks that starting 3 days before the exam they avoid vaginal douching, vaginal medication, tub bathing and sexual intercourse.

    Source ↗ · checked 2026-09-20

  • On the exam day, the center asks patients not to wear lipstick, nail polish or a gel manicure.

    Source ↗ · checked 2026-09-20

Results
  • The center offers a one-stop 'health promotion clinic' where patients bring their checkup report and a physician explains it to them right away, without needing to visit multiple departments.

    Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$1,612–2,279 for a woman (35 of 37 tests) and US$1,664–2,341 for a man (36 of 38 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 3.8 mSv from the tests we could identify, a typical adult dose for these exams: roughly 1.3 years of natural background radiation (about 3 mSv a year, US average).

This package also lists 15 items we have not matched to a test; if any of them is an X-ray, CT or PET scan, the total is higher.

  • Abdominal X-ray (KUB) · about 0.7 mSv
  • Bone density (DXA) · about less than 0.01 mSv
  • Coronary artery calcium score · about 1.7 mSv
  • Spine X-ray · about 1.4 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 15 of these tests
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement, confirmed with measurement outside the clinical setting before starting treatment. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding a coronary artery calcium score to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018; an update is in progress) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF has an update in progress specifically on coronary artery calcium scoring for enhanced cardiovascular risk assessment; the 2018 I statement remains the current final recommendation as of 2026-09-25.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Recommended (grade A/B)The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral weight-loss interventions. (2018; an update is in progress) · USPSTF ↗ Note: The grade applies to offering or referring adults with a BMI of 30 or higher to intensive behavioral weight-loss programs, not to measuring height, weight or BMI; the USPSTF says screening for obesity is now part of routine clinical practice and was not a focus of its review. The USPSTF lists an update in progress, folded into a combined topic on healthy diet, physical activity and weight loss to prevent cardiovascular disease; the 2018 statement remains the current final recommendation as of 2026-09-25.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (2021) · USPSTF ↗
General preparation notes for 9 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Fasting insulin

Usually needs 8 to 12 hours of fasting (no food or drink except plain water) beforehand.

Mention when booking: Mention biotin (vitamin B7) supplements, usually paused for at least a day before this test, and any diabetes medicine; ask the prescribing doctor before changing any medicine.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Coronary artery calcium score

Usually needs about 4 hours without food, caffeine or smoking beforehand; no contrast injection is used for this scan.

Mention when booking: Tell the center if pregnancy is possible.

Afterwards: No recovery time is needed; normal activities can usually resume right away.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Cancer Screening (Afternoon) Plan - Heart Protection
US$561
Book this checkup

If this isn't quite right

Other packages at China Medical University Hsinchu Hospital

All packages at China Medical University Hsinchu Hospital Health Management Center →

Similar packages in Hsinchu

Same tier, other hospitals in Hsinchu, closest in price first.
PackageHospitalTestsPrice
Comprehensive Cancer Screening + Lung ProtectionTon-Yen General Hospital Health Management Center39
US$717
NT$23,000
Platinum Checkup + DigestiveTon-Yen General Hospital Health Management Center35
US$841
NT$27,000

All checkups in Hsinchu →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · Heart and blood vessels · All checkups in Hsinchu · What a checkup costs in Taiwan